Description
Glifo 10 mg contains Empagliflozin, a medication from the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors used to manage type 2 diabetes mellitus. It helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, thereby increasing glucose excretion through urine. In addition to improving glycemic control, Empagliflozin has cardiovascular benefits, such as reducing the risk of cardiovascular death in patients with type 2 diabetes and established heart disease. It is typically taken once daily, with or without food. Common side effects include urinary tract infections, increased urination, and genital infections. The medication is not recommended for patients with significant kidney impairment or type 1 diabetes.
.jpeg)
.webp)
.webp)
.jpeg)
.png)
.png)
.jpeg)
.webp)
.png)
Change Language